投資評等
最後更新日期：2024/11/30
升級(Upgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2009/2/5 | Merriman Curhan Ford | Neutral Buy | |
降級(Downgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->降級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2009/4/14 | Cantor Fitzgerald | Buy Hold | |
| 2007/7/26 | Rodman & Renshaw | Mkt Outperform Mkt Perform | |
首次予以評等(Coverage Initiated)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 目標股價 |
| 2013/5/3 | BioLogic Equity Research | Sell | |
| 2009/10/19 | Brean Murray | Sell | 4 |
| 2004/10/14 | Piper Jaffray | Outperform | 8 |
| 2004/3/3 | JMP Securities | Mkt Outperform | 10 |
恢復投資評等(Coverage Resumed)
| 日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
| 2015/10/23 | Jefferies | Buy | |
重申相同投資評等(Coverage Reiterated)
| 日期/Date | 券商
Brokerage Firm | 重申相同投資評等
Reiterated Rating | 新目標價
New Target |
| 2011/2/23 | JMP Securities | Mkt Outperform | $9 >> $12 |
| 2010/7/29 | Wedbush | Outperform | $12 >> $13 |
| 2009/10/7 | Leerink Swann | Outperform | $9 >> $11 |
| 2009/8/25 | JMP Securities | Mkt Outperform | $13 >> $15 |
| 2008/11/20 | Cantor Fitzgerald | Buy | |
| 2005/7/20 | JMP Securities | Mkt Outperform | |
| 2005/7/20 | Rodman Renshaw | Mkt Outperform | |
| 2004/4/12 | JMP Securities | Mkt Outperform | 10 |
| 2004/2/13 | Stephens Inc | Overweight | 9 |
| 2004/2/12 | Rodman & Renshaw | Mkt Outperform | 9 |